ENDRA Life Sciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 10895.4%.

Top 17 shareholders own 1.18% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
0.43%	Virtu Financial LLC, Asset Management Arm	2,300	US$11.7k	0%	no data
0.13%	L1 Capital Pty. Limited	686	US$3.5k	0%	no data
0.13%	Shamir Capital	686	US$3.5k	0%	0.2%
0.1%	Two Sigma Securities, LLC, Asset Management Arm	548	US$2.8k	0%	no data
0.088%	Tower Research Capital Europe Limited	466	US$2.4k	2,350%	no data
0.076%	Two Sigma Investments, LP	404	US$2.1k	0%	no data
0.074%	Hudson River Trading LLC, Asset Management Arm	395	US$2.0k	110%	no data
0.06%	Jane Street Group, LLC, Asset Management Arm	320	US$1.6k	385%	no data
0.055%	Jump Trading, LLC, Asset Management Arm	291	US$1.5k	0%	no data
0.014%	Morgan Stanley, Investment Banking and Brokerage Investments	74	US$376.6	1,380%	no data
0.011%	Anthony DiGiandomenico	59	US$300.4	0%	no data
0.0038%	Michael Thornton	20	US$101.9	0%	no data
0.0036%	NewEdge Advisors, LLC	19	US$96.8	11.8%	no data
0.00094%	Alexander Tokman	5	US$25.4	0%	no data
0.00038%	Michael Harsh	2	US$10.3	0%	no data
0.00019%	Bank of America Corporation, Asset Management Arm	1	US$5.1	0%	no data
0.00019%	Louis Basenese	1	US$5.1	0%	no data